Candidiasis News and Research

RSS
Candiadiasis, or Thrush, is a fungal infection caused by a group of yeast. There is a score of Candida species, the commonest of which is Candida albicans. They normally inhabit the surfaces and mucus linings of the human body. This includes mouth, vaginal cavity gastrointestinal tract etc.
Friendly bacteria: do we really need to eat probiotic yogurts?

Friendly bacteria: do we really need to eat probiotic yogurts?

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

Sosei completes SO-1105 Phase I trial for oropharyngeal candidiasis in Japan

Sosei completes SO-1105 Phase I trial for oropharyngeal candidiasis in Japan

NovaDigm reports positive data from Phase 1 NDV-3 vaccine program

NovaDigm reports positive data from Phase 1 NDV-3 vaccine program

Sosei initiates SO-1105 Phase I trial in oropharyngeal candidiasis

Sosei initiates SO-1105 Phase I trial in oropharyngeal candidiasis

Candida albicans can sense immune status of host cells and evade them

Candida albicans can sense immune status of host cells and evade them

Affinium initiates AFN-1252 Phase 2 trial in acute bacterial skin & skin structure infections

Affinium initiates AFN-1252 Phase 2 trial in acute bacterial skin & skin structure infections

Woman's ovarian cycle plays an important role in her susceptibility to infection

Woman's ovarian cycle plays an important role in her susceptibility to infection

Effective ways to reduce risk of vaginal yeast infection

Effective ways to reduce risk of vaginal yeast infection

Positive data from NovaDigm's NDV-3 vaccine preclinical study on VVC

Positive data from NovaDigm's NDV-3 vaccine preclinical study on VVC

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Positive data from NovaDigm's NDV-3 vaccine program to be presented at ICAAC conference

Positive data from NovaDigm's NDV-3 vaccine program to be presented at ICAAC conference

Researchers discover how yeast cells identify, attach to human tissue and cause infection

Researchers discover how yeast cells identify, attach to human tissue and cause infection

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings

BioAlliance Pharma enters license deal with Sosei to commercialize Loramyc in Japan

BioAlliance Pharma enters license deal with Sosei to commercialize Loramyc in Japan

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma

Hi-Tech Pharmacal acquires rights to Nystatin Oral suspension ANDA from Bausch + Lomb

Hi-Tech Pharmacal acquires rights to Nystatin Oral suspension ANDA from Bausch + Lomb

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Pevion announces positive results of PEV7 Phase I study for recurrent vulvovaginal candidiasis

Pevion announces positive results of PEV7 Phase I study for recurrent vulvovaginal candidiasis